MILTEFOSE 50

MILTEFOSE 50 is a highly effective antiprotozoal medication containing Miltefosine as its active ingredient. Belonging to the class of alkylphosphocholine compounds, Miltefosine is the first oral medication approved for the treatment of leishmaniasis, a parasitic disease transmitted by the bite of infected sandflies.

Developed to simplify treatment and improve patient outcomes, MILTEFOSE 50 offers a convenient oral therapy alternative to traditional injectable antileishmanial medicines. Manufactured by Steris Healthcare Pvt. Ltd., it meets international quality standards to ensure safety, efficacy, and reliable results in managing parasitic infections.

Uses

MILTEFOSE 50 Capsules are primarily prescribed for the treatment of leishmaniasis, which includes different forms such as:

• Visceral leishmaniasis (Kala-Azar): A severe infection affecting internal organs like the liver, spleen, and bone marrow.

• Cutaneous leishmaniasis: Characterized by skin ulcers and lesions at the site of the sandfly bite.

• Mucocutaneous leishmaniasis: Affects mucous membranes of the nose, mouth, and throat, leading to disfigurement if untreated.

In some cases, Miltefosine is also being explored for its potential use against other parasitic and fungal infections under medical supervision.

Benefits

MILTEFOSE 50 provides several key benefits that make it a preferred treatment for leishmaniasis in both urban and rural healthcare settings:

1. Oral Convenience:
   Unlike older therapies requiring painful injections or hospital administration, MILTEFOSE 50 is an oral capsule, allowing easy, at-home treatment compliance.

2. High Efficacy:
   Miltefosine has demonstrated strong effectiveness in eradicating Leishmania parasites from the bloodstream and tissues, offering high cure rates when used properly.

3. Improved Patient Compliance:
   With a simple dosing regimen, patients are more likely to complete the full course of therapy, which is crucial for successful recovery and preventing recurrence.

4. Broad-Spectrum Activity:
   Effective against various Leishmania species causing visceral, cutaneous, and mucocutaneous forms of the disease.

5. Reduced Need for Hospitalization:
   As it is an oral drug, patients do not require hospital admission or specialized equipment, making it especially useful in resource-limited areas.

6. Well-Tolerated:
   When taken as directed, MILTEFOSE 50 is generally well-tolerated, with manageable side effects compared to older antileishmanial drugs.

Dosage

The dosage of MILTEFOSE 50 Capsules depends on the type of infection, patient’s age, body weight, and medical condition.

Typical Dosage Guidelines:

• Adults: Usually 50 mg capsules taken once or twice daily for 28 days, or as prescribed by a physician.

• Children (above 12 years): Dosage may vary based on body weight and should be determined by a healthcare professional.

Administration Tips:

• Take the capsules with food to minimize stomach upset.

• Swallow whole with water; do not crush or chew.

• Complete the full course, even if symptoms improve early, to prevent relapse or resistance.

Note: Always follow your doctor’s instructions precisely. Do not self-medicate or change dosage without medical advice.

Side Effects

While MILTEFOSE 50 is generally well-tolerated, some patients may experience mild to moderate side effects during treatment.

Common Side Effects:

• Nausea or vomiting

• Diarrhea or stomach discomfort

• Loss of appetite

• Headache or dizziness

• Mild liver enzyme elevation

Serious Side Effects (Rare):

• Severe vomiting or dehydration

• Signs of liver or kidney problems (yellowing of eyes, dark urine, fatigue)

• Allergic reactions (rash, itching, swelling)

• Reproductive toxicity (not recommended during pregnancy)

If any serious symptoms occur, discontinue use and contact your healthcare provider immediately.

Conclusion

MILTEFOSE 50 (Miltefosine Capsules) by Steris Healthcare Pvt. Ltd. represents a major advancement in the treatment of leishmaniasis, providing a safe, convenient, and effective oral option for patients suffering from this debilitating parasitic disease.

Its triple advantage of oral administration, proven efficacy, and broad-spectrum action makes it a trusted choice among healthcare professionals. For best results, patients should adhere strictly to medical advice, maintain proper hydration, and complete the prescribed therapy duration.